Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
The Journal of Gene Medicine|September 29, 2007
Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirusMaarten ter Horst, Eric Brouwer, Suzanne Verwijnen, et al.
International Journal of Molecular Sciences|February 10, 2024
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [<sup>111</sup>In]In-Radioligands: Synthesis and Preclinical ProfileAikaterini Tatsi, Theodosia Maina, Beatrice Waser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Modeling Early Radiation DNA Damage Occurring During <sup>177</sup>Lu-DOTATATE Radionuclide TherapyGiulia Tamborino, Yann Perrot, Marijke De Saint-Hubert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2016
Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous XenograftsMichiel Bolkestein, Erik de Blois, Stuart J Koelewijn, et al.
Neuroendocrinology|January 13, 2012
Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapyEsther I van Vliet, Jaap J M Teunissen, Boen L R Kam, et al.
Bioconjugate Chemistry|March 24, 2007
Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14)Gráinne B Biddlecombe, Buck E Rogers, Monique de Visser, et al.
Nuclear Medicine and Biology|July 13, 2004
Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+Wouter A P Breeman, Maarten Th M De Jong, Erik De Blois, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2015
Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical ModelsSimone U Dalm, Julie Nonnekens, Gabriela N Doeswijk, et al.
Pageof 20